PoulShot MG-F is a live Mycoplasma Vaccine for poultry against Mycoplasma gallisepticum. It has been developed by CAVAC (Choong Ang Vaccine Laboratories Co. Ltd) to control Avian Mycoplasmosis in poultry. It is marketed by Lucky Core Industries (LCI) in Pakistan.
Mycoplasmosis is a common respiratory disease that affects poultry flocks around the world. The disease reduces growth performance, feed efficiency, and egg production.
Features of PoulShot MG-F Vaccine
MG-F contains the F strain of Mycoplasma gallisepticum. The vaccine establishes colonization in the respiratory tract and helps prevent infection by field strains.
This mycoplasma vaccine contributes to respiratory health, improves flock performance, and reduces the impact of Mycoplasma infections.
More Poultry Health Products of LCI
Avian Mycoplasmosis
Avian Mycoplasmosis is caused by Mycoplasma gallisepticum. The disease primarily affects the respiratory tract and can spread rapidly through poultry flocks. Birds may show coughing, nasal discharge, swollen sinuses, reduced feed intake, and decreased productivity.
Mycoplasmosis increases production costs through reduced performance, poor feed conversion, lower egg production, and increased medication expenses.
More LCI Animal Health Products
Role in Poultry Disease Prevention
Vaccination is most effective when combined with strong biosecurity, monitoring programs, and good management practices.
Administration and Dosage of PoulShot MG-F Vaccine
Reconstitute the vaccine with the enclosed diluent before use. Administer one eye drop (0.03 ml) per bird via the ocular route. Vaccinate chickens between 6 and 12 weeks of age to ensure effective immune protection.
Use the vaccine immediately after reconstitution and follow recommended vaccination practices for optimal results.
How to Find in Pakistan?
Click here to contact LCI and find more poultry vaccines
